Symphony Capital Overview
- Investor Type
-
PE/Buyout
- Status
-
Inactive
- Investments
-
10
- Portfolio
-
1
- Exits
-
7
Symphony Capital General Information
Company Description
Symphony Capital was a private equity firm dedicated to invest in the bio pharmaceutical companies. The firm was founded in 2002 and was headquartered in New York, New York
Business Details
Website
www.symphonycapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 485 Madison Avenue
- 7th Floor
- New York, NY 10022
- United States
Symphony Capital Investments (10)
Symphony Capital’s most recent investment was a with The Network Control Group for . The deal was made on 09-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| The Network Control Group | 09-May-2022 | Electronic Equipment and Instruments | Generating Revenue | |||
| The Network Control Group | 28-Aug-2019 | Electronic Equipment and Instruments | Generating Revenue | |||
| Mateon Therapeutics | 09-Dec-2008 | Drug Discovery | Generating Revenue | |||
| DLF Assets | 04-Nov-2008 | Buildings and Property | Generating Revenue | |||
| Symphony ViDA | 30-Sep-2008 | PE Growth/Expansion | Biotechnology | Clinical Trials - Phase 2 |
Symphony Capital Exits (7)
Symphony Capital has made a total of 7 exits. Its latest exit was from Symphony Icon for on 02-Aug-2010. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Symphony Icon | 02-Aug-2010 | ||
| Symphony Dynamo | 04-Jan-2010 | ||
| DLF Assets | 11-Dec-2009 | ||
| Symphony Allegro | 26-Aug-2009 | ||
| Symphony ViDA | 20-Jul-2009 | Merger/Acquisition |
Symphony Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Symphony Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Symphony Capital FAQs
-
What is Symphony Capital?
Symphony Capital was a private equity firm dedicated to invest in the bio pharmaceutical companies.
-
When was Symphony Capital founded?
Symphony Capital was founded in 2002.
-
Where is Symphony Capital headquartered?
Symphony Capital is headquartered in New York, NY.
-
How many investments has Symphony Capital made?
Symphony Capital has made 10 investments.
-
What has Symphony Capital invested in?
Symphony Capital has made numerous investments in companies like The Network Control Group, Mateon Therapeutics, and DLF Assets within the Electronic Equipment and Instruments, Drug Discovery, and Buildings and Property industries.
-
What has Symphony Capital invested in recently?
Symphony Capital's latest investment was on 09-May-2022 in The Network Control Group, a company within the Electronic Equipment and Instruments industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
